FDA compliance vet heads to India-based Lupin after long public career
In a rare move, a long-time veteran of the FDA’s pharma quality and compliance team is moving over to an India-based generic drugmaker with a history of noncompliance.
Diana Amador-Toro, who spent almost four decades with FDA including stints as a program director for the office of pharmaceutical quality operations, was hired in April by Indian generic drug manufacturer Lupin as the company’s senior vice president of global compliance, where she will be handling the company’s compliance function including training, internal audits and investigations.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
